Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.
The US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria. This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17% of the gross domestic product.
There are 3 ways to make the US health care system more efficient and sustainable: address its burdensome complexity, emphasize primary care reimbursement, and regulate drug pricing.
The speed and extent of biosimilar penetration differ across provider types. Provider awareness and incentives are significantly associated with biosimilar uptake.
Patients who enrolled in a trial to lower low-density lipoprotein cholesterol spoke positively of the multifaceted intervention: pillbox monitoring and financial incentives were socially acceptable.
Evaluation of a national retail pharmacy automatic refill program for patients on medication for chronic disease demonstrated significantly improved patient adherence and reduced medication oversupply.
Retail clinic use is associated with lower overall total cost of care based on a matched-pair analysis.
Transitioning from Medicaid fee-for-service to Medicaid managed care was associated with a significant decrease in ambulatory utilization, especially among beneficiaries with 5 or more chronic conditions.
Most non–inborn errors of metabolism (non-IEM) medical foods (MFs) do not meet the regulatory MF definition and lack scientific evidence for safety and efficacy. Non-IEM MFs are not yet ready for reimbursement by public insurers.
This randomized controlled trial finds that a hospital cesarean delivery rate comparison tool affects women’s perceptions but not where they choose to deliver.
Among Medicaid beneficiaries, having more fragmented ambulatory care was associated with a modest independent increase in the hazard of a subsequent emergency department visit.
As delivery reform unfolds and leads to new models of care delivery, social capital will be a powerful concept to incorporate into their design and evaluation.
We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.
There is ample opportunity to integrate digital health technologies into dementia care to promote independent living and prevent unnecessary healthcare utilization.
Preventive service use was better in patients with a usual source of care but little improved by patient-centered medical home status.
This article compares how parents of children seeking specialty care perceive National Committee for Quality Assurance—based patient-centered medical home elements in the primary and specialty care settings.
The authors determined whether Minnesota health systems responded to competitors’ publicly reported performance. Low performers fell further behind high performers, suggesting that reporting was not associated with quality competition.
High-cost patients are only modestly concentrated in specific hospitals and healthcare markets.
Higher medication adherence among Medicaid beneficiaries with congestive heart failure was associated with lower healthcare utilization and lower costs, and the relationship to costs was graded.
Most illnesses today are measured in terms of their effects on daily activities, but who do not always consider the outcomes based on the patient's perspectives. Many clinical studies instead apply standardized measures that identify quality of life as an important outcome. Advancing research methodologies, including new approaches to clinical research, should inform this discussion by centering medical decision making on the preferences of the most important stakeholder-the patient.
Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.